Bombay Super Hybrid Seeds Rating Downgraded by CARE

Long-term bank facilities downgraded to CARE BB+; short-term facilities to CARE A4+.

Reader Takeaway: Persistent non-cooperation with credit agencies signals governance risks and potential liquidity pressure for the firm.

What just happened

CARE Ratings has downgraded the bank facilities of Bombay Super Hybrid Seeds Limited. The agency explicitly moved the long-term facility (Rs 20 crore) from CARE BBB- to CARE BB+, and the long-term/short-term facility (Rs 105 crore) from CARE BBB-/CARE A3 to CARE BB+/CARE A4+. The company remains under the 'ISSUER NOT COOPERATING' tag.

Why this matters

The rating downgrade reflects the agency's inability to assess the company's financial health due to a lack of shared data. CARE Ratings reported that the firm failed to provide necessary information despite three formal requests made in September 2026. For investors, this creates a transparency vacuum, as the market lacks an independent, up-to-date validation of the company's debt-servicing capability.

Risks to watch

Beyond the immediate credit risk, the 'ISSUER NOT COOPERATING' status typically forces lenders to review their credit exposure, which could lead to increased interest costs or a squeeze on existing credit lines. The lack of communication with the rating agency often precedes broader governance or operational challenges, necessitating close scrutiny of upcoming regulatory filings.

What to track next

Investors should closely monitor future BSE filings for any management response regarding the cooperation status. Restoration of communication with the rating agency is essential to stabilize the firm's credit outlook and prevent further erosion of investor confidence.